Response to: 'Blood plasma versus serum: which is right for sampling circulating membrane microvesicles in human subjects?' by Liu et al

Ann Rheum Dis. 2020 Jun;79(6):e74. doi: 10.1136/annrheumdis-2019-215540. Epub 2019 May 16.

Authors

Yasuhiro Kato^{1

2}, JeongHoon Park^{2

3}, Hyota Takamatsu^{4

2}, Atsushi Kumanogoh^{1

2}

Affiliations

¹ Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita City, Japan.
² Laboratory of Immunopathology, WPI Immunology Frontier Research Center, Suita City, Japan.
³ Graduate School of Medicine, Osaka University, Suita City, Japan.
⁴ Department of Respiratory Medicine and Clinical Immunology, Osaka University Graduate School of Medicine, Suita City, Japan [email protected].

PMID: 31097418
DOI: 10.1136/annrheumdis-2019-215540

No abstract available

Keywords: disease activity; systemic lupus erythematosus; treatment.

Publication types

Comment

MeSH terms

Apoptosis
Cell-Derived Microparticles*
Humans
Lupus Erythematosus, Systemic*
Nucleotidyltransferases
Research Subjects

Substances

Nucleotidyltransferases